The immunoassay is a biochemical test which is utilized to quantify the existence of small molecules in a solution. This bio logical technique has been broadly utilized as a part of different pharmaceutical examinations, for example, helpful medication checking, analysis of sicknesses, bioequivalence studies in drug discovery among others. Different regular advances utilized by immunoassays incorporate catalyst connected fluorescence, immunofluorescence, chemiluminescent immunoassay, compound connected immunosorbent examine (ELISA), radioimmunoassay and other comparative methods.
How Big is The Global Immunoassay Reagents and Devices Market?
The Global Immunoassay Reagents and Devices Market is expected to be around US$ 39 Billion by 2028 at a CAGR of 8% in the given forecast period.
The major driving factors of Global Immunoassay Reagents and Devices Market are as follows:
The restraining factors of Global Immunoassay Reagents and Devices Market are as follows:
The Global Immunoassay Reagents and Devices Market is segmented on the lines of its technology, treatment, application and regional. Based on product and service it is segmented as Reagents & Kits it covers Reagents & Kits, by Type it includes Enzyme-linked Immunosorbent Assay (ELISA), Rapid Test Reagents, Western Blot Reagents, ELISPOT Reagents, RIA Reagents and PCR Reagents. It is further consists of Analyzers in analyzers it include purchase mode it consist of Reagent Rental Purchase and Outright Purchase. Further it is segmented as Analyzers, By Type and it includes Open-ended Systems, Closed-ended Systems and Software and Services. It is further segmented by technology it covers ELISA and ELISA can be segmented by platform and by type. In platform it includes Chemiluminescence Immunoassays (CLIA), Fluorescence Immunoassays (FIA) and Colorimetric Immunoassays (CI). In type it includes First Generation, Second Generation, Third Generation and Fourth Generation and above Further the technology is segmented as Rapid Tests, Western Blot, ELISPOT, Radio immunoassays (RIA) and Polymerase Chain Reaction (PCR). It is also segmented on Application which covers Infectious Diseases, Endocrinology, Bone And Mineral Disorders, Oncology, Cardiology, Hematology And Blood Screening, Autoimmune, Diseases, Toxicology, Neonatal Screening and Other Applications. On the basis of End user it is segmented as Hospitals, Clinical Laboratories, Blood Banks, Research & Academic Laboratories, Pharmaceutical Companies, CROs, and Biotechnology Companies and Other End Users. The Global Immunoassay Reagents and Devices Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Immunoassay Reagents and Devices Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Immunoassay Reagents and Devices Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Report scope:
The scope of the report includes a detailed study of global and regional markets on Immunoassay Reagents and Devices Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Siemens AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland),Abbott Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), bioMérieux SA (France) Sysmex Corporation, Alere Inc., , and.Ortho-Clinical Diagnostics, Inc. (U.S.). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Immunoassay Reagents and Devices Market has been segmented as below:
By Product and Service Analysis:
By Technology Analysis:
By Application Analysis:
By End User Analysis:
By Regional Analysis:
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Immunoassay Reagents and Devices Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Immunoassay Reagents and Devices Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
Radio Immunoassay (RIA) Reagents and Devices Market
Computed Tomography Devices Market
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study
3 Executive Summary
3.1 Introduction
3.2 Conclusion
4 Premium Insights
4.1 The Immunoassay Market is Projected to Grow at A Robust Growth Rate From 2019 to 2025
4.2 Geographic Analysis: Global Immunoassay Market, By Product and Service
4.3 Global Immunoassay Market, By Technology
4.4 Geographical Snapshot of the Global Market
4.5 Global Market, By Application
4.6 Global Market, By End User
4.7 Lifecycle Analysis, By Region
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Immunoassay Market: Drivers, Restraints, Opportunities, and Challenges
5.2.2 Drivers
5.2.2.1 Growing Prevalence of Infectious and Chronic Diseases
5.2.2.2 Extensive Use of Immunoassay in Oncology
5.2.2.3 Technological Advancements
5.2.2.4 Cost-Effectiveness & Rapid Analysis
5.2.2.5 Growth in the Biotechnology and Pharmaceutical Sector
5.2.3 Restraints
5.2.3.1 Low Detection Limit of Immunoassay
5.2.3.2 Implementation of Excise Duty By the U.S. Government
5.2.3.3 Stringent Regulations
5.2.4 Opportunities
5.2.4.1 Integration of Microfluidics in Immunoassay
5.2.4.2 Point-Of-Care Testing With Multiplex Assay
5.2.4.3 Emerging Economies
5.2.5 Challenges
5.2.5.1 Pricing Pressure on Manufacturers
6 Immunoassay Market, By Technology
6.1 Introduction
6.2 Enzyme-Linked Immunosorbent Assay (ELISA)
6.2.1 ELISA Market, By Platform
6.2.1.1 Chemiluminescence Immunoassay (CLIA)
6.2.1.2 Fluorescence Immunoassay (FIA)
6.2.1.3 Colorimetric Immunoassay (CI)
6.2.2 ELISA Market, By Type
6.2.2.1 First Generation
6.2.2.2 Second Generation
6.2.2.3 Third Generation
6.2.2.4 Fourth Generation and Above
6.3 Rapid Tests
6.4 Western Blot
6.5 Elispot
6.6 Radioimmunoassay (RIA)
6.7 Polymerase Chain Reaction (PCR)
7 Immunoassay Market, By Product and Service
7.1 Introduction
7.2 Reagents & Kits
7.2.1 By Type
7.2.1.1 Enzyme-Linked Immunosorbent Assay (ELISA) Reagents and Kits
7.2.1.2 Rapid Test Reagents and Kits
7.2.1.3 Western Blot Reagents and Kits
7.2.1.4 Elispot Reagents and Kits
7.2.1.5 RIA Reagents and Kits
7.2.1.6 PCR Reagents and Kits
7.3 Analyzers
7.3.1 By Purchase Mode
7.3.1.1 Reagent Rental Purchase
7.3.1.2 Outright Purchase
7.3.2 By Type
7.3.2.1 Open-Ended Systems
7.3.2.2 Closed-Ended Systems
7.4 Software and Services
8 Immunoassay Market, By Application
8.1 Introduction
8.2 Infectious Diseases
8.3 Endocrinology
8.4 Bone and Mineral Disorders
8.5 Oncology
8.6 Cardiology
8.7 Hematology and Blood Screening
8.8 Autoimmune Disorders
8.9 Toxicology
8.10 Neonatal Screening
8.11 Other Applications
9 Immunoassay Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Clinical Laboratories
9.4 Blood Banks
9.5 Research & Academic Laboratories
9.6 Pharmaceutical Companies, Cros, and Biotechnology Companies
9.7 Other End Users
10 Immunoassay Market, By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe (RoE)
10.4 Asia
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 South Korea
10.4.5 Taiwan
10.4.6 Rest of Asia (RoA)
10.5 Rest of the World (RoW)
11 Competitive Landscape
11.1 Introduction
11.2 Strategic Overview
11.3 Market Share Analysis
11.4 Competitive Situation and Trends
11.4.1 Agreements, Partnerships, and Collaborations
11.4.2 Regulatory Approvals
11.4.3 Expansions
11.4.4 Product Launches
11.4.5 Acquisitions
12 Company Profiles
12.1 Introduction
12.2 F. Hoffmann-La Roche Ltd.
12.3 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
12.4 Bio-Rad Laboratories, Inc.
12.5 Siemens AG
12.6 Sysmex Corporation
12.7 Biomérieux Sa
12.8 Alere Inc.
12.9 Becton, Dickinson and Company
12.10 Ortho Clinical Diagnostics, Inc.
12.11 Abbott Laboratories, Inc.
The Global Immunoassay Reagents and Devices Market has been segmented as below:
By Product and Service Analysis:
By Technology Analysis:
By Application Analysis:
By End User Analysis:
By Regional Analysis:
